---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-312106"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2025-12-09T23:59:59+00:00"
generated_at: "2026-05-16T13:44:37.393800+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bruker appoints diagnostics industry veteran Jack Phillips to board, effective Jan 2026

## Summary
- Jack Phillips appointed to Bruker board effective Jan 1, 2026, filling newly created 11th director seat.
- Phillips previously President & CEO of Accelerate Diagnostics (2020-25) and Roche Diagnostics North America (2010-20).
- CEO Laukien says addition is timely as Bruker broadens infectious disease diagnostics portfolio.
- Phillips will serve until 2027 Annual Meeting; compensation consistent with other non-employee directors.

## SEC filing metadata
- accession: 0001193125-25-312106
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2025-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000119312525312106/0001193125-25-312106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000119312525312106/brkr-20251209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-312106
- JSON: https://secwatch.observer/filing/0001193125-25-312106.json
- Plain text: https://secwatch.observer/filing/0001193125-25-312106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.